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Abstract
THE UTILIZATION OF SEX HORMONE ANTIBODIES FOR SCREENING AND
SEPARATION OF TRACE BIOLOGICAL MIXTURES
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
at Virginia Commonwealth University
by
Kristin Noelle Jones
Bachelor of Science, Liberty University, 2018
Touch or trace evidence consists of epidermal cells deposited by contact with items such
as handled objects, touched surfaces, or worn clothes. This type of evidence has surpassed most
other sample types submitted to forensic labs and typically consists of low quantities of DNA
and multiple contributors. In this study epithelial skin cells, i.e., “touch/trace evidence,” were
used as they are estimated to constitute approximately half of the casework evidence items
submitted for DNA analysis. For the optimization of antibody staining, male and female skin
epithelial samples from donors were incubated and hybridized with antibodies of various
concentrations of Alexa 488-conjugated anti-testosterone antibody (7.00E-4 µg/µL), FITCconjugated anti-DHT antibody (4.10E-4 µg/µL) Alexa 647-conjugated anti-estradiol antibody
(2.00E-4 µg/µL), and Alexa 647-conjugated anti-testosterone (5.00E-4 µg/µL) separately at
varying volumes (1.25, 2.5, 5, and 10 µL). They were also hybridized with combined Alexa 488conjugated anti-testosterone and FITC-conjugated anti-DHT antibody (1.11E-3 µg/µL) at
varying volumes (2.5 and 5 µL). Antibody binding efficiency was assessed by analyzing stained
single-source male, female, and control epithelial skin cells through flow cytometry to determine
if the staining to the specific target was significant when compared to the unstained control. The
objective was to maximize differential binding between contributors, and to increase fluorescent
signal versus noise for antibody binding. Once a staining condition was established, male and
female samples were collected from different individuals and stained to determine if the staining
conditions were consistent with different individuals. It was determined that not all individuals
could be differentiated after staining. However, if an improved signal was observed as
demonstrated by an increased median fluorescence and separation between male and female
samples visualized by overlaying the histograms, then the testing moved forward to FACS
analysis. The results from this study demonstrate that certain contributor cell populations derived
from the epidermis may be differentiated by targeting testosterone, dihydrotestosterone, and
estradiol sex hormones within cell populations as demonstrated by flow cytometry. This study
resulted in a protocol for differentially labeling contributors with anti-steroid antibodies when
compared to the unstained controls. This study has potential application for casework samples to
simplify complex trace mixtures prior to DNA profiling.

Introduction
With the increased sensitivity of forensic analysis in recent years, another type of
evidence submitted to forensic laboratories for analysis has been added. In addition to items of
evidence saturated with biological fluids, evidence called “touch” evidence, consisting of trace
quantities of DNA, is also being submitted (1, 2). Despite the major shift in the types of evidence
laboratories are receiving, techniques to help indicate the presence of trace amounts of biological
material other than blood, semen and saliva such as epithelial cells are not commercially
available (1, 2). To be an effective screening technique, the procedure must require: nondestructive manipulation of the sample, little to no consumption of the sample, and a rapid
processing time much like the many presumptive tests for biological fluids that are commercially
available (3, 4, 5). Currently, there is limited research on effective screening methods for the
indication of epithelial cells in the context of touch/trace evidence (6). However, there are
techniques that utilize instrumentation that exists outside the common operational protocols of
forensic science laboratories which can be utilized to analyze epithelial cells, such as
fluorescence-activated cell sorting (FACS). This technique, referring to the separation of cells
using flow cytometry, utilizes the fluorescent or optical characteristics of cells with or without
the use of antibodies or other probes that interact with specific cell targets (7).
Developing an effective screening technique is the first step in the separation of epithelial
cells, and given the predilection that a large portion of touch evidence in sexual assault cases
comes from male perpetrators, a technique has to be developed in order to specifically detect
male cells present at scenes of those crimes. In particular, a male cell-specific screening device
that is not restricted to seminal fluid would be useful by being incorporated on the front end into
cell separation techniques of complex DNA mixtures of male and female cells. In order to

identify male cells derived from touch evidence rather than sperm cells, male-specific targets
found primarily in skin epithelial cells must be pursued. Theoretically, male-specific hormones
may be appropriate targets. Testosterone, the primary male sex hormone responsible for
producing male phenotypes, may be an effective target due to its abundance in males versus
females, given that male blood serum hormone levels measure approximately 10 times that of
females (8, 9, 10). As a result of the higher prevalence of testosterone in the blood serum of
males, the disparity in testosterone levels found in male and female blood serum may translate to
other tissues and be exploited as a target in order to screen and discriminate between male cells
and female cells with the use of fluorescently labeled anti-testosterone antibodies.
Testosterone is a cholesterol-based hormone and thus is fat soluble and passively passes
through the cell membrane (11). Ninety-seven percent of testosterone is bound by protein
carriers in the blood. Protein bound testosterone circulates via the bloodstream for thirty to sixty
minutes, after which it has either been absorbed by various tissues or degraded to inactive
molecules (12, 13). Once in the cytoplasm of target tissue cells, approximately 10% testosterone
is reduced to dihydrotestosterone (DHT) (14). Dihydrotestosterone (DHT) is an androgen
produced as a byproduct of testosterone. Testosterone is converted to the most potent natural
androgen DHT by the 5ɑ-reductase enzyme that originates from two distinct genes, 1 5areductase (expressed in the liver, kidney, skin, and brain) or type 2 5ɑ-reductase (expressed
strongly in the prostate, hair follicles, and liver) (15). DHT is a potent male sex hormone that is
responsible for things like forming male genitalia during pregnancy.
Both testosterone and DHT can bind to the androgen receptor complex, NR3C4 (nuclear
receptor subfamily 3, group C, member 4), and the entire hormone-androgen receptor complex is
then transported to the nucleus (16). Testosterone not absorbed by tissues will be degraded by the

liver, and the products of this degradation will be excreted from the body (12, 13). It is unclear if
buccal cells are a target of testosterone action; however, there are saliva-based testosterone tests
suggesting that measurable levels of testosterone can be found in saliva (17).
The extent to which fluorescently linked reporter molecules can be used to facilitate a
front-end, contributor-specific, cell screening and separation technique has been reported in
preliminary work but has not been thoroughly investigated (18). In the Miller et al. report,
epithelial cell male-female mixtures were successfully enhanced for male and female DNA
profiles in the post-sort fraction after staining with anti-testosterone and anti-dihydrotestosterone
antibodies prior to cell separation using fluorescently activated cell sorting. A key finding in this
study was that male epithelial cells were not consistently labeled at a greater signal than female
cells. Systematic studies to optimize cell staining with these antibodies may produce more
reproducible and diverse staining patterns that can be exploited for cell sorting and possibly
screening of evidence. Additionally, staining with anti-estradiol may accentuate staining pattern
differences between males and females given that the estradiol levels are significantly higher in
pre-menopausal women than in men, although the levels do vary with the days of a woman’s
menstrual cycle (19).
In this study, skin epithelial cells are utilized, i.e., “touch/trace evidence,” because skin is
a target tissue of testosterone and touch/trace evidence constitutes approximately half of the
casework evidence items submitted for DNA analysis (1, 20). Moreover, touch/trace evidence is
typically comprised of multiple contributors, which often confounds interpretation by STR
profiling (21). Thus, anti-testosterone antibody (anti-T) binding to epithelial skin cells was
optimized in a systematic fashion in order to facilitate contributor specific cell staining and
potential enhancement of one cell population over another. Moreover, to facilitate cell separation,

the use of counterstaining with anti-dihydrotestosterone (anti-DHT) antibodies was explored.
Following the optimization of sex-hormone antibodies, DNA staining was performed in order to
determine if a correlation could be made between DNA staining and hormone staining in the skin
epithelial cells.
This project evaluated and systematically optimized cell staining with these antibodies.
The goals were: 1) to optimize staining of each antibody separately and determine if the staining
to the specific target is significant when compared to the unstained control, 2) to pair antibodies
demonstrated to produce a fluorescent signal above background and determine if pairing the
antibodies enhances the signal intensity (e.g. anti-testosterone and anti-DHT) or facilitates more
distinct staining patterns for male epithelial cells versus female cells (e.g. anti-testosterone or antiDHT and anti-estradiol), 3) to assess whether staining with pairs of antibodies enhances the cell
sorting process, and 4) to quantify the results of cell sorting by statistical analysis, DNA profiling,
and probabilistic modeling. The primary objective of this study was to optimize the experimental
conditions for binding fluorescently labeled anti-testosterone, anti-DHT, and anti-estradiol
antibodies to skin epithelial cells.
Research Materials and Methods
1.

Sample Collection
Epithelial skin cells were collected from consenting male and female volunteers using

two different methods: Whatman® FTA® Sterile Omni Swabs (GE Healthcare, Chicago, IL) and
50 mL conical tubes. Volunteers swabbed the sides of their nose and behind their ears for
approximately 30 seconds with Omni Swabs in order to maximize DNA yield. Additionally,
volunteers gripped conical tubes in their hands for five minutes, regularly twisting to maximize
cell yield. For all samples collected, informed consent was obtained pursuant to VCU-IRB

Protocol ID#HM20000454_CR6.
2.

Optimizing Antibody Staining using Anti-Testosterone
For the optimization of antibody staining, four male and four female skin epithelial

samples were incubated and hybridized with Alexa 488-conjugated anti-testosterone antibody
with a concentration of 7.00E-4 µg/µL (Novus Biologicals, Centennial, CO) at varying volumes
(0, 2.5 µL (1.75E-3 µg), 5 µL (3.5E-3 µg), and 10 µL (7.0E-3 µg) of antibody. For the antibody
staining experiments, epithelial cells were eluted into 2 mL of FACS buffer (1x PBS, 2% FBS,
0.1% sodium azide), washed once, centrifuged at 10,000xg for 10 minutes, and the supernatant
was then decanted to leave 100 µL of buffer. Then 1 µL of blocking buffer (aqueous buffer,
proteins, 0.09% sodium azide) (Thermo Fisher Scientific, Waltham, MA) was added to the cell
suspension with gentle mixing and incubated for 10 minutes on ice. Following the incubation,
varying volumes of Alexa 488-conjugated anti-testosterone antibody (Novus Biologicals) were
added followed by gentle mixing. The solution was then incubated on ice for one hour with
vortexing every 15 minutes. Following the incubation, the cell pellet was washed twice with 1
mL of FACS buffer, prior to flow cytometry analysis.
Antibody binding efficiency was assessed by analyzing stained single-source male and
female epithelial skin cells through the use of the Guava® flow cytometer (Millipore Inc.,
Burlington, MA). Controls consisted of unstained male and female epithelial cells. Flow
Cytometry Standard (.fcs) data files were analyzed to generate histograms using the FlowJo®
software program (BD, Franklin Lakes, NJ). The median fluorescence of the male (blue) and
female (pink) subpopulations stained with anti-testosterone antibody is indicated by a star in
Figure 1. The percent of cells not overlapping at various fluorescence intensities in the
histograms as indicated by the arrow can be used to assess if differences in fluorescence exist

between male and female fractions. The x-axis of the histogram representing fluorescence
intensity was plotted against a y-axis of cell count. Using this data, statistical significance
between male and female samples was determined by performing Two-Sample T-tests of
Unequal Variances using Excel with an alpha of 0.01. This experiment was replicated three more
times with different donors.
3.

Testing and Optimizing Anti-DHT
Anti-DHT staining was optimized as described above for anti-testosterone staining; four

male and four female skin epithelial samples were incubated and hybridized with FITCconjugated anti-DHT with a concentration of 4.10E-4 µg/µL (Novus Biologicals) at varying
volumes (0, 2.5 µL (1.03E-3 µg), 5 µL (2.1E-3 µg), and 10 µL(4.1E-3 µg) of antibody. Antibody
binding efficiency was assessed by analyzing the average median fluorescence calculated from
exported Guava® easyCyte™ data. In addition, differences in fluorescence were determined by
the previously mentioned statistical analysis, with significant differences between male and
female cell populations being a p-value of less than 0.01.
If an enhanced signal, demonstrated by an increased median fluorescence separation
between contributor cell populations visualized by overlaying the histograms, was observed as
well as a significant difference measured by statistical analysis data, then the testing moved
forward to FACS analysis.
4.

Counterstaining with Anti-Testosterone and Anti-DHT
Regardless if the testing and optimization of anti-DHT proved successful, the optimized

probes of anti-testosterone and anti-DHT became a combined protocol for staining to determine
if pairing the antibodies enhanced the signal intensity, facilitating more distinct staining patterns
for male versus female epithelial cells. Using three male and three female skin epithelial

samples, enhanced antibody signal from counterstaining was assessed with the Guava®
easyCyte™ flow cytometer for anti-testosterone and anti-DHT at varying volumes (0, 2.5 µL
(2.78E-3 µg) and 5 µL (5.55E-3 µg) of antibody. Flow Cytometry Standard data files were
analyzed as previously described. The results from the Guava® easyCyte™ flow cytometer with
both antibodies were then compared to previous results generated for anti-testosterone and antiDHT individually. Using this data, statistical significance between male and female samples was
determined as previously described. This experiment was replicated one more time with different
sample donors.
If when overlaying the male and female sample histograms an enhanced signal was
observed demonstrated by an increased median fluorescence separation and was calculated from
exported Guava® easyCyte™ data, then the testing moved forward to FACS analysis.
5.

Testing and Optimizing Anti-Estradiol
Staining cells using Alexa 647-conjugated anti-estradiol antibody (Novus Biologicals,

Centennial, CO) was performed because it has a different fluorescent tag and excitation range
than FITC-conjugated antibodies. In addition, its prevalence in women versus men is far greater
regardless of the varying levels in women during their menstrual cycle (19). Antibody probe
binding efficiency conditions were optimized for anti-estradiol antibody with a concentration of
2.00E-4 µg/µL as described previously for anti-testosterone at varying volumes (0, 1.25 µL
(2.5E-4 µg), 2.5 µL (5.0E-4 µg), and 5 µL (1.0E-3 µg) of antibody, using four male and four
female skin epithelial cell samples. Staining was assessed using the BD FACSCanto™ II flow
cytometer (BD) as anti-estradiol is conjugated with Alexa 647, which required a laser with a 633
nm output that the Guava® easyCyte™ did not possess. Cytometry Standard data files were
analyzed and statistical significance between male and female samples was determined as

previously described. This experiment was replicated one more time with different sample
donors.
6.

Cell Permeabilization Experiment using Triton-X
In order to increase permeabilization of the epithelial cell membranes and thus

theoretically increase antibody staining, a cell permeabilization experiment using Triton-X was
conducted. For the permeabilization experiment, epithelial cells from six male and six female
samples were eluted into 2 mL of FACS buffer, centrifuged at 10,000xg for 10 minutes, and then
the supernatant was removed leaving the pellet. Two PBS Triton-X solutions were made with
solution one being 4 mL PBS with 4 µL Triton-X added, and solution 2 being 4 mL with 16 µL
Triton-X added. From solution one, 2 mL was pipetted into one male and one female sample.
From solution two, 2 mL was pipetted into one male and one female sample. For the remaining
two samples, 2 mL of PBS was added. All twelve samples were incubated at room temperature
for 10 minutes. Following the incubation, the samples were centrifuged at 10,000xg for 10
minutes, and then the supernatant was removed leaving the pellet. Then 1 mL PBS was added to
the samples which were again centrifuged at 10,000xg for 10 minutes. The samples were washed
two more times following the same procedure. After the third wash, the supernatant was
removed leaving 100 µL. Then 1 µL of blocking buffer was added to the cell suspension with
gentle mixing and incubated for 10 minutes on ice. Following the incubation, 2.5 µL (1.75E-3
µg) of Alexa 488-conjugated anti-testosterone antibody (Novus Biologicals, Littleton, CO) was
added to three of both the male and female samples followed by gentle mixing. The solution was
then incubated on ice for one hour, and vortexed every 15 minutes. Following the incubation, the
cell solution was centrifuged at 10,000xg for 10 minutes, the supernatant was removed leaving
the pellet, then 500 µL of PBS was added and vortexed.

Cell permeabilization and antibody binding efficiency was assessed by analyzing stained
single-source male and female epithelial skin cells through the use of the Guava® flow
cytometer. Flow cytometry data files were analyzed and statistical tests were performed as
previously described. This experiment was replicated one more time using different sample
donors.
7.

AMNIS® Imaging Flow Cytometry
Imaging flow cytometry was used to assess whether a subpopulation of cells was stained

with the antibodies and how uniformly the cells were being stained. Imaging Flow Cytometry
was used to answer these questions. Single-source male and female epithelial skin cells were
analyzed through the use of the AMNIS® ImageStream®X Mark II (Millipore Inc., Burlington,
MA) equipped with a 488 nm and 642 nm laser. Images of individual events were captured in
detector channels labeled: 2 (430-505nm) and 5 (640-745nm). Channel 1 was used to capture
Brightfield images, Channel 2 was the target channel for cells stained with anti-testosterone
because of the 488 fluorophore, and Channel 5 was the target channel for cells stained with antiestradiol because of the 647 fluorophore. Magnification was set at 40x and autofocus was
enabled so that the focus varied with cell size. Controls consisted of unstained male and female
epithelial cells.
Raw image file (.rif) data obtained from the AMNIS® instrument were analyzed using the
IDEAS® v. 6.0 Image Data Exploration and Analysis software program (IDEAS®) (Millipore
Inc.). For the purposes of the following AMNIS® experiments intensity, max pixel, and bright
detail intensity conditions were utilized. Intensity is the sum of background subtracted pixel
values within the area of the image. Max Pixel is the largest value of background-subtracted
pixels contained in an image; it is more sensitive than intensity and identifies true positive

events. Bright Detail Intensity computes the intensity of localized bright spots in the area of the
image as observed in Figure 2.
7.1.

AMNIS® Laser Power Experiment

This experiment was performed to determine how the different laser powers affect the
visualization of the antibody staining patterns. The higher the laser power the potentially more
staining pattern detail observed in the cell. The ability to resolve differences in antibody staining
patterns (or spatial distribution) may differ between the same antibody concentration and
different laser power settings. To test which laser power results in the greatest number of infocus large cell images in the IDEAS® software for each antibody used, four male and four
female skin epithelial samples from donors were incubated and hybridized with Alexa 488conjugated anti-testosterone antibody (0, and 2.5 µL (1.75E-3 µg) and Alexa 647-conjugated
anti-estradiol antibody (0, and 2.5 µL (5.0E-4 µg). For the antibody staining experiments,
epithelial cells were eluted into 2 mL of FACS buffer, centrifuged at 10,000xg for 10 minutes,
and the supernatant was removed leaving 100 µL of buffer. Then 1 µL of blocking buffer was
added to the cell suspension with gentle mixing followed by incubation for 10 minutes on ice
(Thermo Fisher Scientific, Waltham, MA). Following the incubation, varying concentrations of
antibody were added followed by gentle mixing. The solution was then incubated on ice for one
hour and vigorously vortexed every 15 minutes. Following the incubation, the cell solution was
washed twice with 1 mL of FACS buffer, prior to analysis.
Antibody binding efficiency was assessed by analyzing stained single-source male and
female epithelial skin cells through the use of the IFC. Controls consisted of unstained male and
female epithelial cells. For this experiment two laser power conditions were being assessed for
each antibody. For the anti-testosterone condition one: 405nm laser was set to 50 mW, 488nm

laser to 50 mW, 561nm laser was off, and 642nm laser was off. Condition two: 405nm laser was
set to 120 mW, 488nm laser to 150 mW, 561nm laser was off, and 642nm laser was off. For the
anti-estradiol condition one: 405nm laser was set to off, 488nm laser was off, 561nm laser to 50
mW, and 642nm laser to 50 mW. Condition two: 405nm laser was set to off, 488nm laser was
off, 561nm laser to 100 mW, and 642nm laser to 150 mW. Data obtained from the AMNIS®
instrument was analyzed using the IDEAS® software program. This experiment was replicated
one more time with different sample donors.
7.2.

AMNIS® Antibody Visualization Experiment

This experiment was performed to determine which antibody concentration has higher
values for intensity, max pixel, and bright detail intensity conditions compared to unstained cells,
and gives the ability to visualize differences in antibody staining patterns with each antibody
concentration with the different antibodies. Three male and three female skin epithelial samples
were incubated and hybridized with Alexa 488-conjugated anti-testosterone antibody (0, 2.5 µL
(1.75E-3 µg), and 5 µL (3.5E-3 µg) of antibody or Alexa 647-conjugated anti-estradiol antibody
(0, 2.5 µL (5.0E-4 µg), and 5 µL (1.0E-3 µg) of antibody following the same procedure
described above for the AMNIS® laser power experiment.
Antibody binding efficiency was assessed by analyzing stained single-source male and
female epithelial skin cells through the use of the AMNIS® ImageStream®X Mark II. Controls
consisted of unstained male and female epithelial cells. Optimal laser power for each antibody
were set based on the results of the laser power experiment. Data obtained from the AMNIS®
instrument was analyzed using the IDEAS® software program. This experiment was replicated
one more time with different sample donors.
7.3.

Using Ideas® Software to Target Nucleated Cells

For the purposes of the following AMNIS® experiment, masks and features were utilized
to determine the possibility of isolating cells with potential nuclei. A mask defines a specific area
of an image to use for displaying feature-value calculations. A feature is described by a
mathematical expression that contains quantitative and positional information about the image
and defines a set of base features that you can use to create features for each object. Data
previously obtained from the AMNIS® instrument that contains potential nuclei was analyzed
using the IDEAS® software program.
8.

DNA Staining Assessed with the AMNIS®
GelGreen® Nucleic Acid Gel Stain (Thermo Fisher Scientific, Waltham, MA) was

selected for DNA staining because it has a sensitivity lower than 0.5 ng, is also nontoxic,
inexpensive, and stable at room temperature. This stain was compared to the SYBR™ Safe DNA
Gel Stain (Thermo Fisher Scientific, Waltham, MA) which is highly sensitive and specifically
formulated to be a less hazardous alternative to ethidium bromide that can utilize either blue light
or UV excitation.
8.1.

Optimizing Alexa 647-Conjugated Anti-Testosterone

GelGreen® has the same excitation range as Alexa 448-conjugated anti-testosterone in
which the 488 nm laser is used. In order to simultaneously observe DNA staining with
GelGreen® and antibody hybridization using anti-testosterone, an anti-testosterone antibody with
a different fluorescent tag and excitation range needed to be used. Thus, antibody hybridization
using Alexa 647-conjugated anti-testosterone antibody (Novus Biologicals) was performed.
Antibody probe binding efficiency conditions were optimized individually first for the new antitestosterone antibody with a concentration of 5.00E-4 µg/µL as described previously for Alexa
647-conjugated anti-estradiol by testing at varying volumes (0, 1.25 µL (6.25E-4 µg), 2.5 µL

(1.25E-3 µg), and 5 µL (2.5E-3 µg) of antibody, using four male and four female skin epithelial
cell samples from sample donors. Staining was assessed using the BD FACSCanto™ II flow
cytometer as this anti-testosterone was conjugated with Alexa 647, which required a laser with a
633 nm output that the Guava® easyCyte™ did not possess. Cytometry Standard (.fcs) data files
were analyzed to generate histograms using the FlowJo® software program (BD, Franklin Lakes,
NJ). Using this data, statistical significance between male and female samples was determined as
previously described. This experiment was replicated one more time using different sample
donors.
8.2.

DNA Dye Optimization

For the DNA staining experiments, epithelial cells from two male and two female
samples were eluted from the swabs collected from the conical tubes into 1 mL of 1 X TrisEDTA (TE) buffer (10 mM Tris-HCl (pH 8.0), 0.1 mM EDTA), and were washed once by
centrifuging at 10,000xg for two minutes to pellet the cells. The supernatant was then removed
by pipetting, and the cells were resuspended in 50 µL of TE buffer. From the cell solution 3 µL
was pipetted onto a glass microscope slide and dried in an incubator at 40°C for two minutes.
Once the cell solution on the slide was dry, the slide was sprayed with a fixative spray to ensure
the cells were fixed to the slide. Cells were then stained with 100-150 µL of GelGreen® Nucleic
Acid Gel Stain or SYBR™ Safe DNA Gel Stain from a 3X dilution in sterile H2O. The
microscope slides with the dye solution were then incubated in an incubator for 30 minutes at
40°C in plastic boxes containing moistened Kimwipes® to ensure the solution on the slide did not
dry out. Following the incubation, the dye solution was then washed from the slide with 2 mL of
sterile H2O.
DNA staining efficiency was assessed by analyzing stained single-source male and

female epithelial skin cells on microscope slides through the use of an Olympus BX40
comparison fluorescent microscope (Olympus Corporation, Tokyo, Japan) with a 40X objective
and BV filter.
8.3.

DNA Staining with GelGreen® and Antibody Hybridization

For the DNA staining experiments, epithelial cells were eluted into 2 mL of FACS buffer,
washed once, centrifuged at 10,000xg for 10 minutes, and the supernatant was removed. The
cells were stained with the addition of 200 μL of GelGreen® Nucleic Acid Gel Stain from a 3X
dilution in sterile H2O. The solution was incubated for 30 minutes at room temperature in the
dark and vortexed every 15 minutes. Following the incubation, the cell solution with the DNA
stain was washed by adding 2 mL FACS buffer and centrifuging at 10,000xg for 10 minutes. The
supernatant was removed and 100 µL of FACS was added to the pellet and vortexed. Then 1 µL
of blocking buffer was added to the cell suspension with gentle mixing and incubated for 10
minutes on ice. Following the incubation, varying volumes (0 and 2.5 µL (1.25 µg)) of Alexa
647-conjugated anti-testosterone antibody were added, followed by gentle mixing. The solution
was then incubated on ice for one hour and vortexed every 15 minutes. Following the incubation,
the cells were washed by adding 1 mL FACS buffer and centrifuging at 10,000xg for 10 minutes.
The supernatant was removed and 100 µL of FACS was added to the pellet and vortexed.
DNA staining efficiency was assessed by analyzing stained single-source male and
female epithelial skin cells through the use of the AMNIS® ImageStream®X Mark II. Controls
consisted of unstained male and female epithelial cells. Data obtained from the AMNIS®
instrument was analyzed using the IDEAS® v. 6.0 Image Data Exploration and Analysis software
program.
9.

Fluorescence Activated Cell Sorting (FACS)

Male-female 1:1 volume:volume epithelial cell mixtures were stained with both antitestosterone and anti-estradiol probes and passed through the Aria-BD FACSAria™ II Cell
Sorter (Beckton Dickinson, Franklin Lakes, NJ) using a 488 nm excitation laser. Data obtained
from the FACS instrument were analyzed using the FACSDiva v. 6.1.3 software program
(Becton Dickinson) to see how the FACS sorting performs with the antibody staining for both
anti-testosterone and anti-DHT. The effectiveness of the FACS sorting was evaluated by STR
profiling and probabilistic modeling to quantify the DNA testing results. This experiment was
replicated one more time with different sample donors. Then DNA analysis of Pre- and Postsorted FACS fractions was performed.
9.1.

DNA analysis of Pre- and Post-sorted FACS fractions

All sorted cell fractions, as well as unsorted mixture samples (used as an initial
reference), were extracted manually with the DNA IQ™ System (Promega, Madison, WI)
following the protocols described in the Virginia Department of Forensic Science (VDFS)
Procedures Manual (22). Purified DNA extracts (~35 µL) and reference DNA samples were
dried down using vacuum centrifugation (SpeedVac, Thermo Fisher Scientific) in low-bind tubes
(Thermo Fisher Scientific, Waltham, MA) and then resuspended in ~13µL with Type I water.
With a few exceptions, only the reference DNA samples were quantified with Promega’s
PowerQuant® System (Promega Corp., Madison, WI) using Applied Biosystem’s 7500
Quantitative PCR instrument (Applied Biosystems [ABI], Carlsbad, CA) following the
manufacturer’s recommendations. After data were collected, the PowerQuant® data were
analyzed using the PowerQuant® Analysis macro provided by Promega Corp.
Short tandem repeat (STR) amplification was performed on the GeneAmp 9700 thermal
cycler (ABI), using Promega’s PowerPlex® Fusion System as described by the manufacturers.

Ten microliters of DNA extract were added to 15 µL of the STR reaction mix for a full volume,
25 µL reaction. STR products were separated on a 3500xl Genetic Analyzer (ABI) with a 24second injection at 1.2 kVolts during injection (15 kVolts during run), followed by STR analysis
with the GeneMapper® ID-X v1.4 or 1.5 software program (ABI) as described in the VDFS
Procedures Manual (22). The analytical threshold that was used to interpret the STR profiles
manually was 75 RFU for each dye channel (22).
Probabilistic genotype modeling analysis was conducted using the TrueAllele® (TA)
Casework system (Cybergenetics, Pittsburgh, PA). The procedure was performed as described in
the TrueAllele Casework user manuals and as described in the Virginia Department of Forensic
Science procedures manual (22). The TA® Casework System can be used to aid the casework
examiner in mixture analysis and likelihood ratio calculations of two, three and four person DNA
mixtures. TA® Casework is a probabilistic modeling approach validated for its effectiveness with
complex mixtures while preserving profile information which may be ignored with traditional
binary statistical approaches.
Results
1.

Optimizing Antibody Staining using Anti-Testosterone
Initial screening of epidermal cells for Alexa 488-conjugated anti-testosterone antibody

probe binding was conducted on 10 different contributor cell populations (five male and five
female samples). Fluorescence histograms of cell populations are shown in Figures 3 and 4.
Probe binding was observed for all antibody concentrations tested as evidenced by shifts in
median fluorescence between unstained and stained cell populations. The female cell populations
had median fluorescence values with standard deviations of 265 ±121, 576 ±124, 556 ±128, and
659 ±116 respectively, while male cell populations had median fluorescence values of 220 ±117,

603 ±108, 656 ±95, and 660 ±104 respectively. The distribution of fluorescence values for each
cell population showed significant variation between individuals with no clear systematic
differences between male and female individuals, as female cell populations stained higher in
some cases while male cell populations stained higher in others (Figure 4). However, some
distinct subpopulations of cells with higher median fluorescence and minimal overlap in
fluorescence histograms were observed as seen highlighted with an arrow in Figure 4.
A statistical comparison between male and female cell subpopulation median
fluorescence values is shown in Figure 5. Following statistical testing, p-values were 7.12E-34
for 0 µL with a median difference of 45 (17%), 1.37E-14 for 2.5 µL (1.75E-3 µg) with a median
difference of 27 (4.5%), 2.98E-117 for 5 µL (3.5E-3 µg) with a median difference of 100 (15%),
and 0.43 for 10 µL (7.0E-3 µg) with a median difference of one (0.15%), respectively. The no
antibody control provides a measure of autofluorescence signal at the measured wavelength.
Overall, staining with Alexa 488 anti-testosterone antibody resulted in an increase in median
fluorescence from unstained to stained cells and showed a greater median fluorescence
separation between male and female cell populations with the addition of 5 µL (3.5E-3 µg) of
antibody.
2.

Testing and Optimizing Anti-DHT
Initial screening of epidermal cells for FITC-conjugated anti-DHT antibody probe

binding was conducted on four contributor cell populations (two male and two female samples).
Fluorescence histograms of cell populations are shown in Figures 6 and 7. Probe binding was
observed across all antibody concentrations tested as evidenced by shifts in median fluorescence
between unstained and stained cell populations (see Figures 6 and 7). The female cell
populations had median fluorescence values with standard deviations of 265 ±121, 323 ±127,

336 ±113, and 372 ±115 respectively, while male cell populations had median fluorescence
values of 220 ±117, 333 ±114, 361 ±120, and 390 ±110, respectively. The subpopulations of
cells had neither distinct higher median fluorescence nor sufficient separation in fluorescence
(Figure 7).
A statistical comparison between male and female cell subpopulation median
fluorescence is shown in Figure 8. Following statistical testing, p-values were 7.12E-34 for 0 µL
with a median difference of 45 (17%), 0.13 for 2.5 µL (1.03E-3 µg) with a median difference of
10 (3%), 4.32E-21 for 5 µL (2.1E-3 µg) with a median difference of 25 (7%), and 0.11 for 10 µL
(4.1E-3 µg) with a median difference of 18 (4.6%) respectively. Overall, staining with FITC
anti-DHT antibody resulted in only a slight increase in median fluorescence from unstained to
stained cells and showed a greater median fluorescence separation between male and female cell
populations with the addition of 5 µL (2.1E-3 µg) of antibody.
3.

Counterstaining with Anti-Testosterone and Anti-DHT
Following the individual optimization of Alexa 488-Conjugated anti-testosterone and

FITC-conjugated anti-DHT antibodies, a screening of epidermal cells for increased probe
binding of the two combined antibodies was conducted on two male and two female samples.
Fluorescence histograms of cell populations generated are shown in Figures 9 and 10. The
female cell populations had median fluorescence values with standard deviations of 272 ±117,
574 ±106, and 614 ±108 respectively, while male cell populations had median fluorescence
values of 265 ±113, 576 ±109, and 644 ±92 respectively. Probe binding was observed across all
samples as evidenced by shifts in median fluorescence between unstained and stained cell
populations. The distribution of fluorescence values for each cell population showed little
variation between individuals with no clear systematic differences between male and female

individuals. However, some potential subpopulations of cells with higher median fluorescence
and minimal overlap in fluorescence histograms were observed, as seen highlighted with arrows
in Figures 10. It cannot be definitely determined visually if there is significant separation due to
the lack of cells present in the male cell subpopulation at that antibody concentration.
A statistical comparison between male and female cell population median fluorescence
values is shown in Figure 11. Following statistical testing, p-values were 0.96 for 0 µL with a
median difference of seven (2.6%), 0.84 for 2.5 µL (2.78E-3 µg) with a median difference of two
(0.35%), and 1.07E-11 for 5 µL (5.55E-3 µg) with a median difference of 30 (4.7%)
respectively. Overall, when anti-testosterone and anti-DHT antibodies were paired, the median
fluorescence increased between unstained and stained cell populations and showed a greater
increased median fluorescence separation between male and female cell populations with the
addition of 5 µL (5.55E-3 µg) of antibody.
Compared to the anti-testosterone individual optimization results, the counterstaining
with anti-DHT did not increase median fluorescence intensity. Following statistical testing, pvalues for the female cell populations were 0.29 for 0 µL, 0.13 for 2.5 µL (2.78E-3 µg), and
1.85E-62 for 5 µL (5.55E-3 µg) of antibody respectively. P-values for the male cell populations
were 1.46E-27 for 0 µL, 2.8E-4 for 2.5 µL (2.78E-3 µg), and 1.99E-5 for 5 µL (5.55E-3 µg) of
antibody respectively. However, compared to the anti-DHT individual optimization results, the
counterstaining with anti-testosterone did increase the median fluorescence values of the male
and female cell populations.
4.

Testing and Optimizing Anti-Estradiol
Initial screening of epidermal cells for Alexa 647-conjugated anti-estradiol antibody

probe binding was conducted on two male and two female samples. Fluorescence histograms of

cell populations generated in FlowJo® are shown in Figures 12 and 13. The female cell
populations had median fluorescence values with standard deviations of 350 ±13, 382 ±81, 410
±121, and 453 ±158 respectively, while male cell populations had median fluorescence values of
350 ±23, 388 ±74, 465 ±138, and 452 ±111 respectively. Probe binding was observed across all
concentrations tested as evidenced by shifts in median fluorescence between unstained and
stained cell populations. The distribution of fluorescence values for each cell population showed
significant variation between individuals with no clear systematic differences between male and
female individuals as female cell populations stained higher in some cases while male cell
populations stained higher in others. However, some distinct subpopulations of cells with higher
median fluorescence and minimal overlap in fluorescence histograms were observed as seen
highlighted with arrows in Figure 13. Previous work has observed that the fluorescent signal of
unstained epithelial cells was greater when utilizing the 633 nm wavelength for fluorophore
detection due to epithelial cell autofluorescence (23).
A statistical comparison between male and female cell population median fluorescence
values is shown in Figure 14. Following statistical testing, p-values were 0.19 for 0 µL with a
median difference of zero (0%), 0.63 for 1.25 µL (2.5E-4 µg) with a median difference of six
(1.5%), 1.37E-11 for 2.5 µL (5.0E-4 µg) with a median difference of 55 (11.8%), and 2.29E-6
for 5 µL (1.0E-3 µg) with a median difference of one (0.22%) respectively. Overall, the results
for anti-estradiol antibody staining showed a greater increased median fluorescence separation
between male and female cell populations with the addition of 2.5 µL (5.0E-4 µg) of antibody.
5.

Cell Permeabilization Experiment using Triton-X
Cell permeabilization of epidermal cells with Triton-X using Alexa 488-conjugated anti-

testosterone antibody was conducted on two male and two female samples. Fluorescence

histograms of cell populations are shown in Figure 15. Probe binding was observed across all
samples as evidenced by shifts in median fluorescence between unstained and stained cell
populations in the histograms. The subpopulations of cells had neither distinct higher median
fluorescence nor sufficient separation in fluorescence.
A statistical comparison between male and female cell subpopulation median
fluorescence is shown in Figure 16. Following statistical testing, p-values were 7.66E-4 with a
median difference of 327 (27%), 3.30E-31 with a median difference of 260 (28%), 6.93E-40
with a median difference of 207 (24.8%), 1.42E-13 with a median difference of 3,111 (13%),
0.02 with a median difference of 758 (3.3%), and 0.16 with a median difference of 1,431 (5.5%)
respectively. Overall, male and female cells stained with 2.5 µL (1.75E-3 µg) of antibody have a
higher median fluorescence compared to unstained cells. However, there is no difference in the
median fluorescence of male and female cells with the addition of Triton-X. Thus, Triton-X
either did not increase permeability of the epithelial cells, or cell permeabilization had no effect
on antibody staining.
6.

AMNIS® Imaging Flow Cytometry
6.1.

AMNIS® Laser Power Experiment

In order to also analyze antibody hybridization for epidermal cell samples using imaging
flow cytometry, laser power (illumination intensities) needed to be tested in order to determine
which condition resulted in the greatest number of in-focus large cell images in the Ideas®
Software for each antibody used.
6.1.1.

Anti-Testosterone

In regards to the cell images, there are both the brightfield and fluorescence imaging of
two individual female and male epidermal cells that have been hybridized with Alexa 488-

conjugated anti-testosterone probes, with the 488 nm laser at 50 mW (condition 1) and 150 mW
(condition 2), and channel 2 (430-505nm) being the channel of interest because of the 488
fluorophore tagged to the antibody (Figure 17). Table 1 compares male and female cell
subpopulation mean intensity, max pixel, and bright detail intensity values of anti-testosterone
AMNIS® laser power experiment experiments. The stained male cells at 50 mW had intensity of
2.33E5, max pixel of 1.55E2, and bright detail intensity of 8.53E3 while at 150 mW the cells had
intensity of 4.74E5, max pixel of 2.99E2, and bright detail intensity of 1.32E4. The stained
female cells at 50 mW had intensity of 1.71E5, max pixel of 3.17E2, and bright detail intensity
of 1.43E4 while at 150 mW the cells had intensity of 3.75E5, max pixel of 7.73E2, and bright
detail intensity of 4.76E4.
For both laser power conditions tested, both male and female cells stained with 2.5 µL
(1.75E-3 µg) of Alexa 488 anti-testosterone had higher values for intensity, max pixel, and bright
detail intensity conditions compared to unstained cells. Both male and female cells captured with
150 mW illumination power have higher values for intensity, max pixel, and bright detail
intensity conditions compared to cells captured with 50 mW illumination power as expected with
increased laser power. Since an increased laser power should also result in increased intensity
values, the primary focus in the scope of this experiment should be bright detail intensity. Bright
detail intensity is more than a measurement of intensity, it also reflects spatial heterogeneity of
pixels across the cell. Based on the bright detail intensity value which increased from 8.53E3 to
1.32E4 in males and from 1.43E4 to 4.76E4 in female, condition two (405nm laser set at 120
mW, 488nm laser at 150 mW, 561nm laser was off, and 642nm laser was off) will be used with
anti-testosterone stained cells.
6.1.2.

Anti-Estradiol

In regards to the cell images, there are both the brightfield and fluorescence imaging of
two individual female and male epidermal cells that have been hybridized with Alexa 647conjugated anti-estradiol probes, with the 642 nm laser set to 50 mW (condition 1) and 150 mW
(condition 2), and channel 5 (640-745nm) being the channel of interest (Figure 18). Table 2
numerically compares male and female cell subpopulation mean intensity, max pixel, and bright
detail intensity values of anti-estradiol for the AMNIS® laser power experiment runs. The stained
male cells at 50 mW had intensity of 1.29E5, max pixel of 8.06E1, and bright detail intensity of
1.52E4 while at 150 mW the cells had intensity of 2.26E5, max pixel of 2.10E2, and bright detail
intensity of 2.96E4. The stained female cells at 50 mW had intensity of 1.97E5, max pixel of
1.40E2, and bright detail intensity of 2.19E4 while at 150 mW the cells had intensity of 5.03E5,
max pixel of 4.11E2, and bright detail intensity of 4.86E4.
For both laser power conditions, male and female cells stained with 2.5 µL (5.0E-4 µg) of
Alexa 647 anti-estradiol had higher values for intensity, max pixel, and bright detail intensity
conditions compared to unstained cells. Both male and female cells captured with 150 mW
illumination power have higher mean values for intensity, max pixel, and bright detail intensity
conditions compared to cells captured with 50 mW illumination power as expected with
increased laser power. As previously stated, bright detail intensity was the primary focus. Based
on the bright detail intensity value which increased from 1.52E4 to 2.96E4 in males and from
2.19E4 to 4.86E4 in female, condition two (405nm laser set at 120 mW, 488nm laser at 150 mW,
561nm laser was off, and 642nm laser was off) will be used with anti-testosterone stained cells.
Female cells have higher mean values than male cells for intensity, max pixel, and bright detail
intensity conditions. Condition two (405nm laser was off, 488nm laser was off, 561nm laser set
to100 mW, and 642nm laser set to 150 mW) will be used with anti-estradiol stained cells.

6.2.

AMNIS® Antibody Visualization Experiment
6.2.1.

Anti-Testosterone

After determining what laser power is most effective with the 488 nm laser for Alexa
488-conjugated anti-testosterone, the next step was to determine which antibody concentration
has higher values for intensity, max pixel, and bright detail intensity conditions compared to
unstained cells and shows the greatest discrepancy between male and female cells. In regards to
the cell images, there are both the brightfield and fluorescence imaging of individual female and
male epidermal cells that have been hybridized with Alexa 488-conjugated anti-testosterone
probes, with the unstained (top), stained with 2.5 µL (1.75E-3 µg) antibody (middle), and stained
with 5 µL (3.5E-3 µg) antibody (bottom) (Figure 19). Something of particular interest was noted
in the male sample seen in Figure 19, for the cell stained with 2.5 µL (1.75E-3 µg) antibody
(middle) appeared to potentially have a nucleus which fluoresced brighter than the rest of the
cell. This same feature was observed in other cells in this particular sample. Also something to
note, the cell does fluoresce in all channels indicating some autofluorescence at the various
wavelengths.
Overall, both male and female cells stained with Alexa 488 anti-testosterone have higher
values for intensity, max pixel, and bright detail intensity conditions compared to unstained cells.
As previously stated, bright detail intensity is the primary focus. Based on the bright detail
intensity value which at 2.5 µL (1.75E-3 µg) was 2.28E4 for males and 2.99E4 for females with
a difference of 7,100, and at 5 µL (3.5E-3 µg) was for 2.61E4 males and 6.91E4 for females with
a difference of 43,000. Cells stained with 5 µL (1.75E-3 µg) of anti-testosterone have higher
values for all three conditions compared to 2.5 µL (1.75E-3 µg), and there is greater discrepancy
between male and female cells with 5 µL (1.75E-3 µg) of antibody added based on the difference

in bright detail intensity values.
6.2.2.

Anti-Estradiol

After determining what laser power is most effective with the 643 nm laser for Alexa
647-conjugated anti-estradiol, the next step was to determine which antibody concentration has
higher values for intensity, max pixel, and bright detail intensity conditions compared to
unstained cells and displays the greatest discrepancy between male and female cells. As
previously stated, bright detail intensity is the primary focus. In regards to the cell images, there
are both the brightfield and fluorescence imaging of individual female and male epidermal cells
that have been hybridized with Alexa 647-conjugated anti-estradiol probes, with the unstained
(top), stained with 2.5 µL (5.0E-4 µg) antibody (middle), and stained with 5 µL (1.0E-3 µg)
antibody (bottom) (Figure 20). For both the male and female samples, fluorescence is observed
with cells that have a size and morphology consistent with epidermal cells.
Overall, both male and female cells stained with Alexa 647 anti-estradiol have higher
values for intensity, max pixel, and bright detail intensity conditions compared to unstained cells.
Based on the bright detail intensity value which at 2.5 µL (5.0E-4 µg) was 4.4E4 for males and
3.74E4 for females with a difference of 6,600, and at 5 µL (1.0E-3 µg) was for 5.49E4 males and
5.77E4 for females with a difference of 2,100. While cells stained with 5 µL (1.0E-3 µg) of antiestradiol have higher values for all three conditions compared to 2.5 µL (5.0E-4 µg), there is
greater discrepancy between male and female cells with 2.5 µL (5.0E-4 µg) of antibody added
based on the difference in bright detail intensity values.
6.2.2.1.

Anti-Testosterone vs. Anti-Estradiol

Following the initial screening and optimization of epidermal cells using the Alexa 488conjugated anti-testosterone and Alexa 647-conjugated anti-estradiol antibodies, male and

female cell populations were compared with respect to intensity, max pixel, and bright detail
intensity using optimized antibody conditions (Figure 21). As previously stated, bright detail
intensity is the primary focus. Female cells stained with both 2.5 and 5 µL of both antitestosterone and anti-estradiol have higher values for intensity, max pixel, and bright detail
intensity conditions compared to unstained cells. The anti-testosterone stained female cells at 2.5
µL (1.75E-3 µg) had intensity of 6.99E5, max pixel of 4.94E2, and bright detail intensity of
2.99E4 while at 5 µL (3.5E-3 µg) the cells had intensity of 6.98E5, max pixel of 8.36E2, and
bright detail intensity of 6.91E4. The anti-estradiol stained female cells at 2.5 µL (5.0E-4 µg)
had intensity of 3.24E5, max pixel of 4.38E2, and bright detail intensity of 3.74E4 while at 5 µL
(1.0E-3 µg) the cells had intensity of 5.85E5, max pixel of 7.04E2, and bright detail intensity of
5.77E4. For intensity, max pixel, and bright detail intensity conditions p-values for 2.5 µL of
antibody were 2.05E-6 for intensity, 0.13 for max pixel, and 0.02 for bright detail intensity,
while p-values for 5 µL of antibody were 0.66 for intensity, 0.66 for max pixel, and 0.76 for
bright detail intensity. Based on the bright detail intensity p-value of 0.02 at 2.5 µL of antibody,
anti-testosterone stained female cells have higher values than anti-estradiol stained cells.
Male cells stained with both 2.5 and 5 µL of both anti-testosterone and anti-estradiol have
higher values for intensity, max pixel, and bright detail intensity conditions compared to
unstained cells. The anti-testosterone stained male cells at 2.5 µL had intensity of 3.65E5, max
pixel of 3.37E2, and bright detail intensity of 2.28E4 while at 5 µL the cells had intensity of
3.98E5, max pixel of 4.07E2, and bright detail intensity of 2.61E4. The anti-estradiol stained
male cells at 2.5 µL had intensity of 3.78E5, max pixel of 5.46E2, and bright detail intensity of
4.40E4 while at 5 µL the cells had intensity of 5.53E5, max pixel of 7.33E5, and bright detail
intensity of 5.49E4. Anti-estradiol stained cells have higher values than anti-testosterone stained

cells for intensity, max pixel, and bright detail intensity conditions. For intensity, max pixel, and
bright detail intensity conditions, p-values for 2.5 µL of antibody were 0.73 for intensity, 5.78E5 for max pixel, and 5.01E-6 for bright detail intensity, while p-values for 5 µL of antibody were
0.01 for intensity, 0.001 for max pixel, and 2.93E-5 for bright detail intensity. Based on the
bright detail intensity p-value of 5.01E-6 at 2.5 µL and 2.93E-5 of antibody at 5 µL, antiestradiol stained male cells have higher values than anti-testosterone stained cells.
Table 3 compares the antibody visualization results on AMNIS® to the antibody
optimization results on the flow cytometers. For the cells stained with anti-testosterone, the
antibody concentration with the greatest discrepancy between male and female cell populations
on Guava® was 5 µL and on the AMNIS® it was 5 µL. This demonstrates that the antitestosterone Guava® and AMNIS® results were consistent, meaning that the data generated from
the flow cytometer was consistent with the data visualized with the imaging flow cytometer.
Comparing the antibody visualization results on AMNIS® to the antibody optimization
results on the flow cytometers for the cells stained with anti-estradiol, the antibody concentration
with the greatest discrepancy between male and female cell populations on Guava® was 2.5 µL
and on the AMNIS® it was 2.5 µL as well. This data demonstrates that the anti-estradiol Guava®
and AMNIS® results were consistent.
6.3.

Using Ideas® Software to Target Nucleated Cells

Following the AMNIS® visualization experiments, where some nuclei were observed in
cell images, an attempt was made to isolate cells with nuclei utilizing morphological and/or
optical features. Being able to isolate cells with nuclei can help one better understand visually
how antibodies interact in the cell where that antibody is synthesized, and demonstrates that
some skin epithelial cells contain intact nuclei where DNA would be present. During this

experiment cell images 60 and 127, which contained nuclei, were used as the templates for
developing features to target potential nuclei in other samples.
Figure 22, a screenshot from the Ideas® Software, depicts cells gated using the Spot(M02,
Ch02, Bright, 5.88, 9, 4) mask. The spot mask is the bright option that obtains bright regions
from an image regardless of the intensity differences from one spot to another. Using this mask,
both cell images 60 and 127 were included in the nuclei gate. However, in total there were 233
cell events also included in that gate that did not contain nuclei, making this mask too general.
Figure 23, a screenshot depicting cells gated using the Intensity(M02, Ch02, 250-500)
mask. The intensity mask uses pixels between the lower and upper raw intensity thresholds in a
specified range to generate data. Using this mask, only cell image 127 was included in the nuclei
gate. While the number of cells included in the nuclei gate was reduced to 18 cell events, the gate
did not include cell image 60 so this mask was not suitable to use as it may exclude some cells
with nuclei.
Figure 24, a screenshot from the Ideas® Software, depicts cells gated using the combined
Spot(M02, Ch02, Bright, 5.88, 9, 4) And Intensity(M02, Ch02, 250-500) mask. This mask
combines the two previously described masks. Using this mask, both cell images 60 and 127
were included in the nuclei gate. However, there were a total of 370 cell events also included in
that gate that did not contain nuclei, making this mask too general.
Figure 25, a screenshot from the Ideas® Software, depicts cells gated using the combined
Spot (M02, Ch02, Bright, 5.88, 9, 4) And Morphology(M02, Ch02) mask. This mask combines a
previously described mask as well as morphology, which is used in fluorescence images and best
used for calculating the values of overall shape-based features. Using this mask, both cell images
60 and 127 were included in the nuclei gate. However, there were a total of 370 cell events also

included in that gate that did not contain nuclei, making this mask too general.
Figure 26 depicts cells gated using the combined Component 1, (Circularity, Spot(M02,
Ch02, Bright, 5.88, 9, 4), Ascending) mask. This mask combines a previously described mask as
well as circularity, which measures the degree of the mask’s deviation from a circle. The closer
the object to a circle the smaller the variation, and therefore, the feature value will be high. Using
this mask, only cell image 127 was included in the nuclei gate. While the number of cells
included in the nuclei gate was reduced to 77 cell events, because the gate did not include cell
image 60, this mask was not suitable to use as it may exclude some cells with nuclei.
Table 4 summarizes all of the Ideas® Software data from each gate used to target
nucleated cells. For the Spot(M02, Ch02, Bright, 5.88, 9, 4) mask in total there were 233 cell
events included in that gate that did not contain nuclei in addition to the two cell that did,
however, it contained both target cells as well as the least number of other non-target cells,
making it best suited to isolate cells with potential nuclei.
7.

DNA Staining Assessed with the AMNIS®
Due to unforeseen issues that occurred with FACS sorting, it was not possible to assess

whether staining with pairs of antibodies enhances the cell sorting process and thus results of cell
sorting could not be quantified by statistical analysis or probabilistic modeling. Following the
issues with FACS sorting, it was decided to try DNA staining on AMNIS® using a new antibody,
Alexa 647-conjugated anti-testosterone, which had the greatest separation between male and
female cell populations of all the antibodies used.
7.1.

Optimizing Alexa 647-Conjugated Anti-Testosterone

Initial screening of epidermal cells for Alexa 647-conjugated anti-testosterone antibody
probe binding was conducted on two male and two female samples. Fluorescence histograms of

cell populations generated in FlowJo® are shown in Figures 27 and 28. Probe binding was
observed across all concentrations tested as evidenced by shifts in median fluorescence between
unstained and stained cell populations. The female cell populations had median fluorescence
values with standard deviations of 2463 ±3887, 15695 ±18682, 26728 ±34146, and 51801
±59324, respectively, while male cell populations had median fluorescence values of 2084
±2130, 6140 ±10474, 8940 ±11937, and 15445 ±18506, respectively. Interestingly, the
fluorescent signal of unstained epithelial cells was greater when utilizing the 633 nm wavelength
compared to the 488 nm wavelength for fluorophore detection, likely due to epithelial cell
autofluorescence (22). However, some distinct subpopulations of cells with higher median
fluorescence and minimal overlap in fluorescence histograms were observed as seen in Figure
28.
A statistical comparison between male and female cell subpopulation median
fluorescence calculated from exported Canto data is shown in Figure 29. Following statistical
testing, p-values were 1.79E-44 for 0 µL with a median difference of 379 (16%), 0.00 for 1.25
µL (6.25E-4 µg) with a median difference of 9,555 (60.9%), 0.00 for 2.5 µL (1.25E-3 µg) with a
median difference of 17,788 (66.6%), and 0.00 for 5 µL (2.5E-3 µg) with a median difference of
36,356 (70.2%) respectively. Overall, the results for anti-testosterone antibody staining showed a
greater increased median fluorescence separation between male and female cell populations with
the addition of 2.5 µL (1.25E-3 µg) of antibody.
Overall, female and male cells stained with Alexa 647 anti-testosterone have higher
median fluorescence than all other antibody-stained cells at all antibody concentrations, and the
greatest discrepancy between male and female cells making it the best antibody for
hybridization.

7.2.

DNA Dye Optimization

Once the Alexa 647 anti-testosterone antibody was optimized, a comparison was then
conducted between the GelGreen® Nucleic Acid Gel Stain and SYBR™ Safe DNA Gel Stain,
both of which are sensitive commercially available DNA stains. Once the optimal excitation
filter on the microscope was determined, two male and two female donors were stained with
GelGreen® and SYBR™ Safe to determine which would best stain skin epithelial cells to be
observed with AMNIS®. Upon comparison it was determined that both DNA stains fluoresced
equally, and so GelGreen® was chosen for the DNA staining experiment on AMNIS® because of
its safer non-mutagenic properties.
7.3.

DNA Staining with GelGreen® and Antibody Hybridization

Following the optimization of the DNA stains and determination to move forward with
the GelGreen® stain for the experiment on AMNIS®, male and female cell samples were prepared
using the combined DNA stain and antibody hybridization protocol. The male and female
samples were run on the AMNIS®, however, because this sort of experiment has yet to be
published in literature it was unsure how the results would turn out. It was expected that the
GelGreen® would fluoresce in the green channel while the Alexa 647 anti-testosterone antibody
would fluoresce in the red channel. However, this was not the case as the antibody did not
fluoresce at all. It was determined that more would need to be done with the DNA staining
experiment in order to determine the best way to effectively combine the two protocols.
8.

Fluorescence Activated Cell Sorting (FACS)
Following antibody staining optimization using flow cytometers and antibody

visualization utilizing the AMNIS®, it was decided to move forward with FACS sorting using
anti-testosterone and anti-estradiol. Figure 30 displays the FACS sorting data with anti-

testosterone (left) and anti-estradiol (right). Both the reports for the anti-testosterone antibody
and the anti-estradiol show an apparent single peak in the histograms of the 1:1 male:female
mixtures rather than two separate peak populations. These results contradict earlier results found
in the Miller et al. report where two distinct peaks were observed in the FACS gate histograms.
When the sorted male and female cell fractions were subjected to DNA analysis and the
results were analyzed, no male DNA was present in the electropherograms. This could be the
result of improper mixing when aliquoting pre- and post-sort fractions or biological factors of the
male epidermis stratum corneum skin layer. As a result of two failed FACS sorts, a new
approach to the project was taken. It was determined that a DNA staining experiment be
conducted in order to determine if the antibody was in the epithelial cells and if those epithelial
cells contained DNA as well. This would help determine if the cells that were staining with the
antibody actually contained DNA. If not, then that would help explain the lack of DNA found in
post-sort samples.
When conducting the DNA staining experiment, a new antibody had to be optimized in
order to simultaneously visualize antibody and DNA staining in separate AMNIS® channels. An
anti-testosterone antibody with a different fluorescent tag and excitation range needed to be used
as GelGreen® shared the same fluorophore as the Alexa 488-conjugated anti-testosterone. It was
decided to also test this antibody, Alexa 647-conjugated anti-testosterone, with FACS sorting.
Figure 31 shows the report from FACS sorting with Alexa 647-conjugated anti-testosterone that
shows separation of peaks from a 1:1 male:female mixture in solution. The skin epidermal cells
in the mixture were incubated with the Alexa 647 anti-testosterone antibody and physically
sorted into two fractions: P5 “left” or P6 “right”. When sorted, the gated P5 fraction contained
33,204 cells and the gated P6 fraction contained 34,643 cells. Based on the Alexa 647 anti-

testosterone optimization histogram peak characteristics for both the male and female cell
populations, it was expected that the P5 post-sort fraction contained the female profile, while the
male profile was expected to be enriched from the P6 post-sort fraction. However, something to
note is that at the 633 nm wavelength, a higher autofluorescence was observed with unstained
cells which could result in P5 being autofluorescence and P6 being the stained male and female
cell populations.
8.1.

DNA analysis of Pre- and Post-sorted FACS fraction

After DNA typing the pre-sort mixture, P5 and P6 post-sort fractions, and male and
female donor reference samples, it was determined that each sorted fraction contained alleles
consistent with both male and female contributors as well as an unknown third contributor. In the
pre-sort mixture STR typing profile chart depicted in Figure 32, the alleles were consistent with
both the male and female contributors with a greater number of alleles attributed to the male. In
the post-sort P5 fraction STR typing profile chart depicted on the left in Figure 32, the few
alleles present were consistent with both the male and female contributors with a greater number
of alleles attributed to the male. In the post-sort P6 fraction STR typing profile chart depicted on
the right in Figure 32, the alleles were consistent with both the male and female contributors with
a greater number of alleles attributed to the male. It should be noted that in the pre-sort and both
post-sort fractions there were alleles not attributable to either the female or male contributors,
marked with an asterisk in Figure 32. The presence of extra alleles is not unusual in trace
evidence samples given the low template DNA quantity; however, some of the same noncontributor alleles can be observed in both pre-sort and post-sort fractions, suggesting that it is
possible the extraneous DNA was introduced during sampling.
Following STR analysis of the samples, a quantitative assessment was performed on the

profiles to determine the uncertainty of those genotypes when comparisons were performed
between reference samples and both the pre- and post-sort fractions. This quantitative assessment
was done using TrueAllele® Casework (TA) analysis.
Analysis of the pre-sort mixture indicated statistical support for the male contributor in
the unsorted mixture (Log(LR) 29), but no statistical support for the female contributor (Log(LR)
1.3), consistent with the large number of male alleles and the minimal number of unique female
alleles observed. Interestingly, analysis for the male and female contributors in the P5 left
fraction was inconclusive (both Log(LR) <0) (Table 5), consistent with the minimal number of
alleles observed and excessive allelic and locus dropout. However, analysis of the P6 right
fraction indicated statistical support for the male contributor (Log(LR) 9), but no statistical
support for the female contributor (Log(LR) inconclusive). The P6 results were consistent with
‘the large number of male alleles and the minimal number of female alleles above detection
threshold.
Discussion
Overall, the results from this study show that contributor cell populations from trace
biological samples may be differentiated by targeting testosterone, dihydrotestosterone, and
estradiol sex hormones within forensically relevant epithelial cell samples. One unexpected
result from these experiments was that epithelial cell populations from female contributors often
showed higher affinity for testosterone antibody probes compared to epithelial cell populations
from male contributors. Another unexpected result from these experiments was that epithelial
cell populations from male contributors often showed higher affinity for estradiol antibody
probes compared to epithelial cell populations from female contributors. There are several
possible explanations for these unexpected results, but they complicate the cell separation and

prevent the use of a “one size fits all” application of the gating criteria.
One explanation is that hormone levels can vary between individuals of not only the
different sexes but within the same sex as well due to lifestyle variables (smoking increases
testosterone), changes in reproductive organ function (affected by medications), body
composition, age, and ethnicity (19, 24, 25, 26, 27). For the samples collected, no information
was known about the donors aside from sex pursuant to our collection protocols. As a result, it is
difficult to determine if any of these explanations are the cause for the unexpected results.
Another explanation is that hormone molecules within the skin’s epidermal tissue can be
influenced by factors such as cellular turnover rate and biochemical profile of the epidermis (28).
Yet another potential explanation is that epidermal thickness is a major factor in the ability of
hormone antibodies to bind to hormones within the cell. In one study of nearly 100 individuals, it
was found that males had a thicker cellular epidermis than females (29). This supports the theory
that males have thicker epidermal skin layers than females, and that if the male cells are fully
keratinized they are less likely to contain DNA (30).
One explanation as to why the FACS separation did not work with the DNA yield being
so low in sorted cell populations is the potential prevalence of extracellular DNA (eDNA) versus
intracellular DNA (31, 32, 33). Early research suggests 70% of contact samples contained eDNA
which added value to the STR profiles generated from the pelleted cellular material, while later
research suggests the DNA in touch samples are comprised of as much as 84-100% eDNA (31,
32). This in part impacted the resolution of the FACS separation, where the cells depicted in the
histograms did not necessarily have enough DNA for effective DNA profiling. The skin
epithelial cells used in this study go through a process known as keratinization, where the cells
display gradual shrinking of the nucleus as they migrate towards the surface and the cells are

filled with keratin (30). As such, these cells have minimal DNA content. In the FACS
experiments conducted, the pre-sort fractions always had more DNA than the post-sort fraction,
most likely because of the presence of eDNA and the fact that during the sorting process eDNA
is likely dissociated from the cells. Thus the presence of eDNA, which could be the result of
cellular apoptosis and/or bodily fluid secretions, may be a factor in a successful FACS separation
(33).
The impact of one or more of the previously mentioned factors on the epithelial skin cells
used in this study could explain unexpected antibody binding results, as well as the variability
across individuals using the same antibody. Despite this, the optimization of hormone antibodies
using epithelial skin cells was able to be conducted due to reproducible differences in the
antibody staining signatures. The overall purpose of this study was to determine if it was possible
to facilitate separation between the male and female cell populations, which was deemed
possible.
Conclusion
1.

Conclusions of the Research
The results from this study show that male and female trace epithelial cells can be stained

by targeting testosterone, dihydrotestosterone, and estradiol sex hormones within cell
populations and differentiated by flow cytometry. Anti-testosterone and anti-estradiol staining of
epithelial cells yields a significant difference when compared to unstained cells, as well as
between male and female cell populations. The same cannot be said of anti-DHT or anti-DHT
paired with anti-testosterone.
More research is needed in order to determine if trace epithelial cell mixtures can be
simplified prior to DNA profiling by targeting testosterone and estradiol sex hormones within cell

populations followed with FACS sorting to separate populations. However, this study shows
promising results for optimizing sex hormone antibodies, DNA staining, and targeting cells with
nuclei in software programs.
2.

Impact
Using Alexa 488-conjugated anti-testosterone, FITC-conjugated anti-DHT, Alexa 647-

conjugated anti-estradiol, and Alexa 647-conjugated anti-testosterone antibodies as fluorescent
tags to screen for male epithelial cells is an innovative concept that could benefit forensic
biology units with casework. Preferential labeling of male cells can be utilized for screening at
crime scenes and in the lab to identify where male cells, and presumably male DNA, are present
on evidence. However, in order to develop a screening tool, preferential or sufficiently different
(from females) labeling of male cells must be conclusively demonstrated. Flow cytometry was
used as a tool for determining if preferential labeling of male cells could be achieved with the
additional benefit of cell mixture simplification prior to DNA analysis. Mixture simplification
prior to DNA analysis would have a major impact not only in creating DNA mixtures which are
easier to interpret, but also post-sort fractions which provide greater statistical power given
enhancement for contributors in the different fractions. Overall, insights generated from this
technique will contribute to the improvement of forensic science and our understanding of
epithelial skin cell evidence in particular. This in turn, may influence DNA sampling on evidence
items which could result in the production of higher quality DNA profiles.
3.

Future Directions
3.1.

Fluorescence Activated Cell Sorting (FACS)

A major goal of this study was to couple protocols for antibody staining to Fluorescence
Activated Cell Sorting (FACS). The purpose of performing FACS was to physically isolate cell

populations prior to DNA profiling and demonstrate that touch mixtures can be resolved using
this approach. Isolation of cells was possible with antibody staining, which could help
differentiate between male and female cell populations in a mixture. However, after three
attempts at FACS, resolving mixtures of male and female DNA was not possible because of
insufficient material used for running through the FACS. Further research will need to be
performed in order to optimize the protocol for antibody staining to FACS in order to minimize
DNA loss and increase reproducibility.
3.2.

DNA Staining with GelGreen® and Antibody Hybridization

It was expected that the GelGreen® would fluoresce in the green channel while the Alexa
647 anti-testosterone antibody would fluoresce in the red channel. However, this was not the
case as the antibody did not fluoresce at all. More experimentation will need to be done with the
DNA staining experiment in order to determine the best way to effectively combine the two
protocols.
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Critical Data: Tables
Table 1. Mean Intensity, Max Pixel, and Bright Detail Intensity Values of Anti-Testosterone.

Data compares laser powers and conditions in the AMNIS® laser power experiment.

Table 2. Mean Intensity, Max Pixel, and Bright Detail Intensity Values of Anti-Estradiol.

Data compares laser powers and conditions in the AMNIS® laser power experiment.

Table 3. Summary of AMNIS® results.

Flow cytometry results were compared to imaging flow cytometry results to determine
consistency between the two for each antibody.

Table 4. Summarized Ideas® Software Data.
Using Ideas® Software to Target Nucleated Cells
Mask Name
Spot(M02, Ch02, Bright, 5.88, 9, 4)

Includes Target Cells 60 and 127
Number of Cell Events
(Y/N)
233

Yes

18

No, just cell 127

Spot(M02, Ch02, Bright, 5.88, 9, 4) And
Intensity(M02, Ch02, 250-500)

370

Yes

Spot(M02, Ch02, Bright, 5.88, 9, 4) And
Morphology(M02, Ch02)

370

Yes

77

No, just cell 127

Intensity(M02, Ch02, 250-500)

Component(1, Circularity, Spot(M02, Ch02,
Bright, 5.88, 9, 4), Ascending)

Various masks were compared to determine most effective in isolating cells with potential
nuclei.

Table 5. TrueAllele ® Casework analysis for Alexa 647 anti-testosterone 1:1 male:female mixture.

The logarithm of the likelihood ratio (log(LR)) values, regarding the statistical support of female
and male STR profiles as contributors to the pre-sort mixture, P5 post-sort, and P6 post-sort
fraction, are displayed.

Critical Data: Figures

Figure 1. Testing and Comparing Male and Female Cell Subpopulations. The median
fluorescence of the male (blue) and female (pink) subpopulations stained with anti-testosterone
antibody is indicated by a star. The percent of cells not overlapping at various fluorescence
intensities in the histograms as indicated by the arrow can be used to determine if differences in
fluorescence exist between male and female fractions.

Figure 2. Bright Detail Intensity. Bright detail intensity is defined as the intensity of localized
bright spots in the area of the epithelial cell image using the AMNIS® external software program
(IDEAS® v. 6.0 Image Data Exploration and Analysis User’s Manual, Millipore Inc., Burlington,
MA, 2013).
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Figure 3. Panel A & Panel B. Testing and Comparing Female and Male Cell Subpopulations
Stained with Varying Concentrations of Anti-Testosterone linked to Alexa 488. Female cells are
Panel A, male cells are Panel B. These gated histograms represent unstained and stained cells at
various anti-testosterone antibody concentrations starting with unstained and proceeding with
unstained, 2.5 µL (1.75E-3 µg/µL), 5 µL (3.5E-3 µg/µL), and 10 µL (7.0E-3 µg/µL). These
histograms demonstrate if there was a shift from the unstained to stained cells. X-axis is
fluorescence intensity, y-axis is cell count.
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Figure 4. Comparing Male and Female Cell Subpopulations Stained with Varying
Concentrations of Anti-Testosterone. The median fluorescence of the male (blue) and female
(pink) subpopulations stained with anti-testosterone antibody. Arrow indicates area of
nonoverlap.

Figure 5. Comparison between male and female cell populations stained with anti-testosterone.
Bars represent median fluorescence. Asterisk represents statistical significance when p < 0.01
with an alpha of 0.01.
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Figure 6. Panel A & Panel B. Testing and Comparing Female and Male Cell Subpopulations
Stained with Varying Concentrations of Anti-DHT. Female cells are Panel A, male cells are
Panel B. These gated histograms represent unstained and stained cells at various anti-DHT
antibody concentrations starting with unstained and proceeding with unstained, 2.5 µL (1.02E-3
µg/µL), 5 µL (2.1E-3 µg/µL), and 10 µL (4.1E-3 µg/µL) . These histograms demonstrate if there
was a shift from the unstained to stained cells. X-axis is fluorescence intensity, y-axis is cell
count.
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Figure 7. Comparing Male and Female Cell Subpopulations Stained with Varying
Concentrations of Anti-DHT. The median fluorescence of the male (blue) and female (pink)
subpopulations stained with anti-DHT antibody.

Figure 8. Comparison between male and female cell populations stained with antidihydrotestosterone (anti-DHT). Bars represent median fluorescence. Asterisk represents
statistical significance when p < 0.01 with an alpha of 0.01.
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Figure 9. Panel A & Panel B. Testing and Comparing Female and Male Cell Subpopulations
Stained with Varying Concentrations of Anti-Testosterone and Anti-DHT. Female cells are Panel
A, male cells are Panel B. These gated histograms represent unstained and stained cells at various
anti-testosterone and anti-DHT antibody concentrations starting with unstained and proceeding
with unstained, 2.5 (2.78E-3 µg), and 5 µL (5.55E-3 µg). These histograms demonstrate if there
was a shift from the unstained to stained cells. X-axis is fluorescence intensity and y-axis is cell
count.
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Figure 10. Comparison of male and female cell populations stained with varying concentrations
of anti-Testosterone and anti-DHT. The male cells are shown in blue and female in pink. Arrows
indicate peaks of female and male cell populations respectively.

Figure 11. Comparison between male and female cell populations stained with both antitestosterone and anti-dihydrotestosterone. Bars represent median fluorescence. Asterisk
represents statistical significance when p < 0.01 with an alpha of 0.01.
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Figure 12. Panel A & Panel B. Testing and Comparing Female and Male Cell Subpopulations
Stained with Varying Concentrations of Anti-Estradiol. Female cells are Panel A, male cells are
Panel B. These gated histograms represent unstained and stained cells at various anti-estradiol
antibody concentrations starting with unstained and proceeding with unstained, 1.25 µL (2.5E-4
µg/µL), 2.5 µL (5.0E-4 µg/µL), and 5 µL (1.0E-3 µg/µL). These histograms demonstrate if there
was a shift from the unstained to stained cells. X-axis is fluorescence intensity and y-axis is cell
count.
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Figure 13. Comparing Male and Female Cell Subpopulations Stained with Varying
Concentrations of Anti-Estradiol. The median fluorescence of the male (blue) and female (pink)
subpopulations stained with anti-estradiol antibody. Arrows indicate peaks of female and male
cell populations respectively.

Figure 14. Comparison between male and female cell populations stained with anti-estradiol.
Bars represent median fluorescence. Asterisk represents statistical significance when p < 0.01
with an alpha of 0.01.

Figure 15. Cell Permeabilization Experiment using Triton-X. The median fluorescence of the
male (blue) and female (pink) populations stained with Alexa 488-conjugated anti-testosterone
antibody. (Top Row) Comparing Male and Female Cell Subpopulations Stained with Varying
Concentrations of Triton-X and 0 Antibody Added (0, 1, and 4 µL). (Bottom Row) Comparing
Male and Female Cell Subpopulations Stained with Varying Concentrations of Anti-Testosterone
Antibody and Triton-X Added (0, and 2.5 µL (1.02E-3 µg/µL)).

Figure 16. Comparison of the effect of Triton-X 100 cell permeabilization on subsequent
staining with anti-testosterone antibody. Male and female cell populations were tested with and
without Triton-X 100 (Triton) and with 2.5 µL (1.02E-3 µg/µL) of anti-testosterone. Asterisk
represents statistical significance when p < 0.01 with an alpha of 0.01.
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Figure 17. Panel A & Panel B. Anti-Testosterone Female and Male Cells Stained 50 mW (top)
vs Stained 150 mW (bottom). Female cells are top two image rows, male cells are bottom two
image rows. The same donors were stained with 2.5 µL (1.02E-3 µg/µL) of anti-testosterone and
subjected to different laser powers in order to determine which laser power gave the highest data
results for Intensity, Max Pixel, and Bright Detail Intensity in Channel 2.
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Figure 18. Panel A & Panel B. Anti-Estradiol Female and Male Cells Stained 50 mW (top) vs
Stained 150 mW (bottom). Female cells are top two image rows, male cells are bottom two
image rows. The same donors were stained with 2.5 µL (5.0E-4 µg/µL) of anti-estradiol and
subjected to different laser powers in order to determine which laser power gave the highest data
results for Intensity, Max Pixel, and Bright Detail Intensity in Channel 5.
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Figure 19. Panel A & Panel B. Anti-Testosterone Female and Male Cells Unstained (top) vs 2.5
Stained (middle) vs 5 Stained (bottom). Female cells are top three image rows, male cells are
bottom three image rows. The same donors were stained with various antibody concentrations of
0, 2.5 (1.75E-3 µg/µL), and 5 µL (3.5E-3 µg/µL) of anti-testosterone to determine which
antibody concentration gave the highest data results for Intensity, Max Pixel, and Bright Detail
Intensity in Channel 2.
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Figure 20. Panel A & Panel B. Anti-Estradiol Female and Male Cells Unstained (top) vs 2.5
Stained (middle) vs 5 Stained (bottom). Female cells are top three image rows, male cells are
bottom three image rows. The same donors were stained with various antibody concentrations of
0, 2.5 (5.0E-4 µg/µL), and 5 µL (1.0E-3 µg/µL) of anti-estradiol to determine which antibody
concentration gave the highest data results for Intensity, Max Pixel, and Bright Detail Intensity in
Channel 5.
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Figure 21. Panel A & Panel B. Anti-Estradiol vs. Anti-Testosterone Female and Male AMNIS®
antibody. Female results are top, male results are bottom. Used to determine which antibody has
the greater values at the three specified parameters of intensity, max pixel, and bright detail
intensity.

Figure 22. Utilization of the Ideas® Software to Target Nucleated Cells, using the Spot(M02,
Ch02, Bright, 5.88, 9, 4) mask. A mask defines a specific area of an image to use for displaying
feature-value calculations. The x-axis is the area which represents the number of microns
squared in a mask (1 pixel = 0.25 µm2), the y-axis is the aspect ratio which represents how round
or oblong an object is. Green dots represent in-focus large cells and yellow dots represent cells
gated for potential nuclei using the mask.

Figure 23. Utilization of the Ideas® Software to Target Nucleated Cells, using the
Intensity(M02, Ch02, 250-500) mask. A mask defines a specific area of an image to use for
displaying feature-value calculations. The x-axis is the area which represents the number of
microns squared in a mask (1 pixel = 0.25 µm2), the y-axis is aspect ratio which represents how
round or oblong an object is. Green dots represent in-focus large cells and yellow dots represent
cells gated for potential nuclei using the mask.

Figure 24. Utilization of the Ideas® Software to Target Nucleated Cells, using the combined
Spot(M02, Ch02, Bright, 5.88, 9, 4) And Intensity(M02, Ch02, 250-500) mask. A mask defines
a specific area of an image to use for displaying feature-value calculations. The x-axis is the area
which represents the number of microns squared in a mask (1 pixel = 0.25 µm2), the y-axis is
aspect ratio which represents how round or oblong an object is. Green dots represent in-focus
large cells and yellow dots represent cells gated for potential nuclei using the mask.

Figure 25. Utilization of the Ideas® Software to Target Nucleated Cells, using the combined
Spot(M02, Ch02, Bright, 5.88, 9, 4) And Morphology(M02, Ch02) mask. A mask defines a
specific area of an image to use for displaying feature-value calculations. The x-axis is the area
which represents the number of microns squared in a mask (1 pixel = 0.25 µm2), the y-axis is
aspect ratio which represents how round or oblong an object is. Green dots represent in-focus
large cells and yellow dots represent cells gated for potential nuclei using the mask.

Figure 26. Utilization of the Ideas® Software to Target Nucleated Cells, using the combined
Component(1, Circularity, Spot(M02, Ch02, Bright, 5.88, 9, 4), Ascending) mask. A mask
defines a specific area of an image to use for displaying feature-value calculations. The x-axis is
the area which represents the number of microns squared in a mask (1 pixel = 0.25 µm2), the yaxis is aspect ratio which represents how round or oblong an object is. Green dots represent infocus large cells and red dots represent cells gated for potential nuclei using the mask.
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Figure 27. Panel A & Panel B. Testing and Comparing Female and Male Cell Subpopulations
Stained with Varying Concentrations of Anti-Testosterone. Female cells are Panel A, male cells
are Panel B. These gated histograms represent unstained and stained cells at various antitestosterone antibody concentrations starting with unstained and proceeding with unstained, 1.25
µL (6.3E-4 µg/µL), 2.5 µL (1.3E-3 µg/µL), and 5 µL (2.5E-3 µg/µL). These histograms
demonstrate if there was a shift from the unstained to stained cells. X-axis is fluorescence
intensity, y-axis is cell count.
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Figure 28. Comparing Male and Female Cell Subpopulations Stained with Varying
Concentrations of Anti-Testosterone. The median fluorescence of the male (blue) and female
(pink) subpopulations stained with anti-testosterone antibody.

Figure 29. Comparison between male and female cell populations stained with anti-testosterone.
Bars represent median fluorescence. Asterisk represents statistical significance when p < 0.01
with an alpha of 0.01.

Figure 30. Reports from FACS sorting 1:1 male:female epidermal cell mixtures. Sorting was
performed with Alexa 488-conjugated anti-testosterone (left, middle) and Alexa 647-conjugated
anti-estradiol (right). Histograms in the reports show little to no separation of 1:1 male:female
mixtures in solution.

Figure 31. Report from FACS sorting 1:1 male:female mixture with Alexa 647-conjugated antitestosterone. Histogram in report shows separation of peaks from 1:1 male:female mixture in
solution. Plots below the histograms represent the gates for both the P5 and P6 post-sort fractions.

Panel A

Figure 32. Panel A. PowerPlex® Fusion STR typing profile of the pre-sorted fraction of Alexa 647
anti-testosterone mixture. Alleles belonging to the male contributor are highlighted in blue, alleles
belonging to the female contributor are highlighted in pink, and alleles that can be contributed to
both the male and female profiles are split blue and pink. Alleles that belong to a third contributor
are highlighted in white with an asterisk (*). Parentheses (#) denote a minor allele, and [#] denote
alleles below analytical threshold.
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Figure 32. Panel B & Panel C. PowerPlex® Fusion STR typing profile of the P5 post-sort fraction
of Alexa 647 anti-testosterone mixture. Panel B. P6 post-sort fraction. Alleles belonging to the
male contributor are highlighted in blue, alleles belonging to the female contributor are highlighted
in pink, and alleles that can be contributed to both the male and female profiles are split blue and
pink. Alleles that belong to a third contributor are highlighted in white with an asterisk (*).
Parentheses (#) denote a minor allele, and [#] denote alleles below analytical threshold.
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